🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will test whether the Proteus Sustained Behavior Change (SBC) Sys...
Status
Withdrawn
Location
Northwestern University
Start Date
2012-02
Trial ID
NCT01503008
The purpose of this research was to assess the absolute and relative incide...
Status
Completed
Location
Research Site
Start Date
2004-09
Trial ID
NCT01077323
Treatments Being Tested
The purpose of this study is to determine the long-term safety of the study...
Status
Completed
Location
Akaicho Clinic
Start Date
2019-03-30
Trial ID
NCT03861039
Treatments Being Tested
To investigate the secretion of gut hormones, in particular glucagon-like p...
Status
Completed
Location
Dept. of Endocrinology
Start Date
2016-08
Trial ID
NCT02879955
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of MP-513 ...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01301833
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
Pyridostigmine is an acetylcholinesterase inhibitor, which degrades acetylc...
Status
Terminated
Location
University of Florida Clinical Research Center
Start Date
2015-08
Trial ID
NCT02357225
Treatments Being Tested
Type II diabetes mellitus (T2DM) is a chronic disease associated with a ver...
Status
Recruiting
Location
Azienda Ospedaliera Sant'Anna e San Sebastiano
Start Date
2025-09-08
Trial ID
NCT07314684
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of 2 diffe...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01106651
Treatments Being Tested
Primary Objective: To assess the mean change in HbA1c (glycated haemoglobi...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-30
Trial ID
NCT02954692